Blog
RSS FeedPosted by Michael Wonder on 30 May 2019
PHARMAC fails to score major funding boost in NZ budget
30 May 2019 - Major new funding for mental health but not for medicines; face of Wellbeing budget has given ...
Posted by Michael Wonder on 30 May 2019
Proposals for funding in the neurology, immunosuppressants, diabetes and anti-thrombotic therapy areas
30 May 2019 - PHARMAC is seeking feedback on proposals for funding in the neurology, immunosuppressant, diabetes and anti-thrombotic therapy ...
Posted by Michael Wonder on 28 May 2019
Feilding woman nervous about PHARMAC's decision to change epilepsy medication brands
28 My 2019 - Judy Lawrence recalls vividly the day she suffered a seizure walking down the stairs eight years ...
Posted by Michael Wonder on 28 May 2019
PHARMAC head defends drug agency's funding
28 May 2019 - PHARMAC is under intense pressure from clinicians, health advocacy groups and patients to fund more medicines ...
Posted by Michael Wonder on 28 May 2019
1500 New Zealanders access a cure for hepatitis C
27 May 2019 - Over 1500 New Zealanders have started a new hepatitis C treatment in the last three months ...
Posted by Michael Wonder on 27 May 2019
Guyon Espiner investigates PHARMAC: NZ diabetes drugs 'third world' - doctor
28 May 2019 - An endocrinologist says New Zealand's type 2 diabetes drugs are 'third world'. Why won't Pharmac fund the ...
Posted by Michael Wonder on 27 May 2019
Breast cancer treatments, rare disorders, venlafaxine
27 May 2019 - PHARMAC has published more information on its decisions on the funding of medicines for breast cancer, ...
Posted by Michael Wonder on 27 May 2019
PHARMAC playing 'money game' by not funding drug 49 other countries back - campaigner
27 May 2019 - Pharmac is playing a "money game" while patients are dying, an advocate for a patient group ...
Posted by Michael Wonder on 26 May 2019
PHARMAC switches epilepsy drug against Medsafe advice
27 May 2019 - PHARMAC is making 10,000 people with epilepsy change medication even though Medsafe opposed the move. Guyon Espiner ...
Posted by Michael Wonder on 23 May 2019
Drugs and money
24 May 2019 - An extra $60 million for PHARMAC over the next four years will benefit more than 30,000 New ...
Posted by Michael Wonder on 23 May 2019
Guyon Espiner investigates PHARMAC: the secret list
24 May 2019 - Desperate patients are being left in the dark as to when PHARMAC will fund medicines. Guyon Espiner ...
Posted by Michael Wonder on 22 May 2019
Guyon Espiner investigates PHARMAC: The NZ Buyer’s Club
23 May 2019 - Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other New Zealanders ...
Posted by Michael Wonder on 21 May 2019
Official Information Act response: PrEP data
20 May 2019 - PHARMAC responds to a request for information relating to the funding of tenofovir disoproxil fumarate with ...
Posted by Michael Wonder on 21 May 2019
Official Information Act response: adrenaline auto-injector cost utility analysis
20 May 2019 - PHARMAC responds to a request for any cost utility analyses performed by PHARMAC in relation to ...
Posted by Michael Wonder on 19 May 2019
Cost of EpiPens putting children at risk, specialists say
19 May 2019 - Children with life-threatening allergies whose families cannot afford to pay for EpiPen auto-injectors are at serious ...